Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.590954
Title: The role of pregnane-X-receptor in liver fibrosis
Author: Haughton, Emma Louise
Awarding Body: University of Aberdeen
Current Institution: University of Aberdeen
Date of Award: 2007
Availability of Full Text:
Access through EThOS:
Full text unavailable from EThOS. Please try the link below.
Access through Institution:
Abstract:
Liver fibrosis is a wound healing response to chronic hepatocellular damage. The activated pregnane X receptor has been shown to exert an anti-fibrogenic effect in rodent chronic liver injury in vivo models. The aim of this study was to determine the effects of the human pregnane X receptor on hepatic stellate cell trans-differentiation to a pro-fibrogenic phenotype in vitro. Primary hepatic stellate cells were isolated from resected human liver and cultured under conditions in which they trans-differentiated into a pro-fibrogenic phenotype with increased expression of extracellular matrix components, cytokines and chemokines. Here we have demonstrated that the pregnane X receptor was expressed in primary cultures of hepatic stellate cells as well as a hepatic stellate cell line at the level of mRNA and protein, and was transcriptionally functional as determined by increased ER6-dependent reporter gene expression. Short term treatment of hepatic stellate cells with pregnane X receptor ligands such as rifampicin resulted in an increase in interleukin-6 secretion as well as an inhibition in DNA synthesis. Interleukin-6 promoter studies in primary hepatic stellates and the LX-2 hepatic stellate cell line suggested that the activated protein-1 site and nuclear factor interleukin-6 sites were required for pregnane X receptor-mediated regulation. Chronic ligand treatment over several weeks resulted in reduced proliferation and trans-differentiation of hepatic stellate cells with no obvious effect on the rate of apoptosis. We therefore conclude that the pregnane X receptor is transcriptionally active in human hepatic stellate cells and that activators inhibit the trans-differentiation and proliferation in culture. The pregnane X receptor may therefore be an effective target for anti-fibrotic therapy.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.590954  DOI: Not available
Share: